Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer-Reference-Cited by-同舟云学术

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

Published:2010-06 Issue:3 Volume:12 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Creighton Chad J,Fu Xiaoyong,Hennessy Bryan T,Casa Angelo J,Zhang Yiqun,Gonzalez-Angulo Ana Maria,Lluch Ana,Gray Joe W,Brown Powell H,Hilsenbeck Susan G,Osborne C Kent,Mills Gordon B,Lee Adrian V,Schiff Rachel

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr2594.pdf

Reference58 articles.

1. Lin N, Winer E: Advances in adjuvant endocrine therapy for postmenopausal women. J Clin Oncol. 2008, 26: 798-805. 10.1200/JCO.2007.15.0946.

2. Osborne C: Steroid hormone receptors in breast cancer management. Breast Cancer Res Treat. 1998, 51: 227-238. 10.1023/A:1006132427948.

3. Cui X, Schiff R, Arpino G, Osborne CK, Lee AV: Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol. 2005, 23: 7721-7735. 10.1200/JCO.2005.09.004.

4. Conneely O, Jericevic B, Lydon J: Progesterone receptors in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia. 2003, 8: 205-214. 10.1023/A:1025952924864.

5. Bardou V-J, Arpino G, Elledge RM, Osborne CK, Clark GM: Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases. J Clin Oncol. 2003, 21: 1973-1979. 10.1200/JCO.2003.09.099.

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2/PI3K/AKT pathway in HER2-positive breast cancer: A review;Medicine;2024-06-14

2. HS‐10352 in hormone receptor‐positive, HER2‐negative advanced breast cancer: A phase 1 dose‐escalation trial;Cancer Medicine;2023-12

3. Impact of somatic mutations and transcriptomic alterations on cancer aneuploidy;Biomedical Research;2023-09-27

4. A PI3K gene expression signature predicts for recurrence in early‐stage non–small cell lung cancer treated with stereotactic body radiation therapy;Cancer;2023-08-10

5. Tipifarnib Potentiates the Antitumor Effects of PI3Kα Inhibition in PIK3CA- and HRAS-Dysregulated HNSCC via Convergent Inhibition of mTOR Activity;Cancer Research;2023-06-20